Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer : A Prospective Observational Study

NCT03022162 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT03022162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03022162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer : A Prospective Observational Study
Lead sponsor
Tata Memorial Centre
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
May 31, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, neuropathic pain